EXEC: Nike Faces Stock Price Cuts, Downgrade Following Disappointing Q1 Report
EXEC: Nike Faces Stock Price Cuts, Downgrade Following Disappointing Q1 Report SGB Media
Covered in this story
Analyst targets on Nike, Inc.
- BNP Paribas Exane: $33.9 → $19 by Oct 2027 · Underperform via Investing.com
- Wells Fargo: $35.1 → $30 by Oct 2027 · Equal Weight via Investing.com
- Jefferies: $35.1 → $60 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $NKE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nike, Inc. →Dalsna Finance is currently tracking 12 stories mentioning Nike, Inc., the earliest published 23 Sept 2026.
Summary aggregated from SGB Media's public RSS feed. The full reporting belongs to SGB Media — please read it on their site.